A citation-based method for searching scientific literature


List of co-cited articles
179 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
Toshana L Foster, Harry Wilson, Shilpa S Iyer, Karen Coss, Katie Doores, Sarah Smith, Paul Kellam, Andrés Finzi, Persephone Borrow, Beatrice H Hahn,[...]. Cell Host Microbe 2016
103
88

The IFITM proteins inhibit HIV-1 infection.
Jennifer Lu, Qinghua Pan, Liwei Rong, Wei He, Shan-Lu Liu, Chen Liang. J Virol 2011
266
77

The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.
Yimeng Wang, Qinghua Pan, Shilei Ding, Zhen Wang, Jingyou Yu, Andrés Finzi, Shan-Lu Liu, Chen Liang. J Virol 2017
36
77

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Alex A Compton, Timothée Bruel, Françoise Porrot, Adeline Mallet, Martin Sachse, Marine Euvrard, Chen Liang, Nicoletta Casartelli, Olivier Schwartz. Cell Host Microbe 2014
118
77

IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
Kevin Tartour, Romain Appourchaux, Julien Gaillard, Xuan-Nhi Nguyen, Stéphanie Durand, Jocelyn Turpin, Elodie Beaumont, Emmanuelle Roch, Gregory Berger, Renaud Mahieux,[...]. Retrovirology 2014
84
77

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.
Jingyou Yu, Minghua Li, Jordan Wilkins, Shilei Ding, Talia H Swartz, Anthony M Esposito, Yi-Min Zheng, Eric O Freed, Chen Liang, Benjamin K Chen,[...]. Cell Rep 2015
101
66

SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
Yoshiko Usami, Yuanfei Wu, Heinrich G Göttlinger. Nature 2015
246
55

HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.
Annachiara Rosa, Ajit Chande, Serena Ziglio, Veronica De Sanctis, Roberto Bertorelli, Shih Lin Goh, Sean M McCauley, Anetta Nowosielska, Stylianos E Antonarakis, Jeremy Luban,[...]. Nature 2015
241
55

IFITM proteins restrict viral membrane hemifusion.
Kun Li, Ruben M Markosyan, Yi-Min Zheng, Ottavia Golfetto, Brittani Bungart, Minghua Li, Shilei Ding, Yuxian He, Chen Liang, James C Lee,[...]. PLoS Pathog 2013
214
44

SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.
Chetan Sood, Mariana Marin, Ajit Chande, Massimo Pizzato, Gregory B Melikyan. J Biol Chem 2017
70
44

Effect of HIV-1 Env on SERINC5 Antagonism.
Saina Beitari, Shilei Ding, Qinghua Pan, Andrés Finzi, Chen Liang. J Virol 2017
49
44

Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.
Alex A Compton, Nicolas Roy, Françoise Porrot, Anne Billet, Nicoletta Casartelli, Jacob S Yount, Chen Liang, Olivier Schwartz. EMBO Rep 2016
62
33

The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.
Samad Amini-Bavil-Olyaee, Youn Jung Choi, Jun Han Lee, Mude Shi, I-Chueh Huang, Michael Farzan, Jae U Jung. Cell Host Microbe 2013
208
33

Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins.
Jin Qian, Yann Le Duff, Yimeng Wang, Qinghua Pan, Shilei Ding, Yi-Min Zheng, Shan-Lu Liu, Chen Liang. Virology 2015
30
33

Δ20 IFITM2 differentially restricts X4 and R5 HIV-1.
Wan-Lin Wu, Christopher Robert Grotefend, Ming-Ting Tsai, Yi-Ling Wang, Vladimir Radic, Hyungjin Eoh, I-Chueh Huang. Proc Natl Acad Sci U S A 2017
20
33


IFITMs restrict the replication of multiple pathogenic viruses.
Jill M Perreira, Christopher R Chin, Eric M Feeley, Abraham L Brass. J Mol Biol 2013
145
33

Ifitm3 limits the severity of acute influenza in mice.
Charles C Bailey, I-Chueh Huang, Christina Kam, Michael Farzan. PLoS Pathog 2012
154
33

Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.
Kevin Tartour, Xuan-Nhi Nguyen, Romain Appourchaux, Sonia Assil, Véronique Barateau, Louis-Marie Bloyet, Julien Burlaud Gaillard, Marie-Pierre Confort, Beatriz Escudero-Perez, Henri Gruffat,[...]. PLoS Pathog 2017
35
33

Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction.
Tsai-Yu Lin, Christopher R Chin, Aaron R Everitt, Simon Clare, Jill M Perreira, George Savidis, Aaron M Aker, Sinu P John, David Sarlah, Erick M Carreira,[...]. Cell Rep 2013
68
33

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
Tanay M Desai, Mariana Marin, Christopher R Chin, George Savidis, Abraham L Brass, Gregory B Melikyan. PLoS Pathog 2014
178
33

The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.
Rui Jia, Qinghua Pan, Shilei Ding, Liwei Rong, Shan-Lu Liu, Yunqi Geng, Wentao Qiao, Chen Liang. J Virol 2012
119
33


Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
Stuart J D Neil, Trinity Zang, Paul D Bieniasz. Nature 2008
33

S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.
Ajit Chande, Emilia Cristiana Cuccurullo, Annachiara Rosa, Serena Ziglio, Susan Carpenter, Massimo Pizzato. Proc Natl Acad Sci U S A 2016
48
33

SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx.
Nadine Laguette, Bijan Sobhian, Nicoletta Casartelli, Mathieu Ringeard, Christine Chable-Bessia, Emmanuel Ségéral, Ahmad Yatim, Stéphane Emiliani, Olivier Schwartz, Monsef Benkirane. Nature 2011
33

A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV.
Molly OhAinle, Louisa Helms, Jolien Vermeire, Ferdinand Roesch, Daryl Humes, Ryan Basom, Jeffrey J Delrow, Julie Overbaugh, Michael Emerman. Elife 2018
39
33

CD4 Expression and Env Conformation Are Critical for HIV-1 Restriction by SERINC5.
Xihe Zhang, Jing Shi, Xusheng Qiu, Qingqing Chai, Dylan A Frabutt, Richard C Schwartz, Yong-Hui Zheng. J Virol 2019
19
33

Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer.
Dmitry Lyumkis, Jean-Philippe Julien, Natalia de Val, Albert Cupo, Clinton S Potter, Per-Johan Klasse, Dennis R Burton, Rogier W Sanders, John P Moore, Bridget Carragher,[...]. Science 2013
521
33

A membrane topology model for human interferon inducible transmembrane protein 1.
Stuart Weston, Stephanie Czieso, Ian J White, Sarah E Smith, Paul Kellam, Mark Marsh. PLoS One 2014
47
22

The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.
Sinu P John, Christopher R Chin, Jill M Perreira, Eric M Feeley, Aaron M Aker, George Savidis, Sarah E Smith, Andrew E H Elia, Aaron R Everitt, Mehul Vora,[...]. J Virol 2013
114
22


IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus.
Rajini Mudhasani, Julie P Tran, Cary Retterer, Sheli R Radoshitzky, Krishna P Kota, Louis A Altamura, Jeffrey M Smith, Beverly Z Packard, Jens H Kuhn, Julie Costantino,[...]. J Virol 2013
85
22

The IFITMs Inhibit Zika Virus Replication.
George Savidis, Jill M Perreira, Jocelyn M Portmann, Paul Meraner, Zhiru Guo, Sharone Green, Abraham L Brass. Cell Rep 2016
132
22

IFITM3 restricts the morbidity and mortality associated with influenza.
Aaron R Everitt, Simon Clare, Thomas Pertel, Sinu P John, Rachael S Wash, Sarah E Smith, Christopher R Chin, Eric M Feeley, Jennifer S Sims, David J Adams,[...]. Nature 2012
488
22


Interferon induction of IFITM proteins promotes infection by human coronavirus OC43.
Xuesen Zhao, Fang Guo, Fei Liu, Andrea Cuconati, Jinhong Chang, Timothy M Block, Ju-Tao Guo. Proc Natl Acad Sci U S A 2014
100
22

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
I-Chueh Huang, Charles C Bailey, Jessica L Weyer, Sheli R Radoshitzky, Michelle M Becker, Jessica J Chiang, Abraham L Brass, Asim A Ahmed, Xiaoli Chi, Lian Dong,[...]. PLoS Pathog 2011
380
22

A diverse range of gene products are effectors of the type I interferon antiviral response.
John W Schoggins, Sam J Wilson, Maryline Panis, Mary Y Murphy, Christopher T Jones, Paul Bieniasz, Charles M Rice. Nature 2011
22

HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.
Kosuke Miyauchi, Yuri Kim, Olga Latinovic, Vladimir Morozov, Gregory B Melikyan. Cell 2009
472
22

Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
Xuesen Zhao, Mohit Sehgal, Zhifei Hou, Junjun Cheng, Sainan Shu, Shuo Wu, Fang Guo, Sylvain J Le Marchand, Hanxin Lin, Jinhong Chang,[...]. J Virol 2018
55
22


The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Abraham L Brass, I-Chueh Huang, Yair Benita, Sinu P John, Manoj N Krishnan, Eric M Feeley, Bethany J Ryan, Jessica L Weyer, Louise van der Weyden, Erol Fikrig,[...]. Cell 2009
849
22


Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.
J Sodroski, R Patarca, C Rosen, F Wong-Staal, W Haseltine. Science 1985
552
22

Serine Phosphorylation of HIV-1 Vpu and Its Binding to Tetherin Regulates Interaction with Clathrin Adaptors.
Tonya Kueck, Toshana L Foster, Julia Weinelt, Jonathan C Sumner, Suzanne Pickering, Stuart J D Neil. PLoS Pathog 2015
41
22

Regulating protein breakdown through proteasome phosphorylation.
Jordan J S VerPlank, Alfred L Goldberg. Biochem J 2017
54
22

The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G.
Silvestro G Conticello, Reuben S Harris, Michael S Neuberger. Curr Biol 2003
387
22

LC3C Contributes to Vpu-Mediated Antagonism of BST2/Tetherin Restriction on HIV-1 Release through a Non-canonical Autophagy Pathway.
Ursula Madjo, Olivier Leymarie, Stéphane Frémont, Aurelia Kuster, Mélanie Nehlich, Sarah Gallois-Montbrun, Katy Janvier, Clarisse Berlioz-Torrent. Cell Rep 2016
26
22

A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells.
O T Fackler, D Wolf, H O Weber, B Laffert, P D'Aloja, B Schuler-Thurner, R Geffin, K Saksela, M Geyer, B M Peterlin,[...]. Curr Biol 2001
43
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.